Pig-islet xenotransplantation: recent progress and current perspectives.

Area of Science:

• Biomedical Science
• Transplantation Immunology
• Endocrinology

Background:

• Islet xenotransplantation offers a potential solution for the shortage of human pancreatic islets for diabetes treatment.
• Pigs are a viable source for islets due to availability, but challenges include insufficient islet yield and xenograft rejection.
• Preclinical studies have advanced understanding of immune responses and rejection mechanisms in xenotransplantation.

Purpose of the Study:

• To review the current status and challenges of pig islet xenotransplantation for diabetes.
• To highlight advancements in islet isolation, purification, and immunotherapeutic strategies.
• To assess the potential for clinical translation of pig islet xenotransplantation.

Main Methods:

• Review of preclinical studies on pig islet isolation, purification, and transplantation in diabetic models.
• Analysis of data on xenograft survival, immune responses, and insulin independence.
• Evaluation of novel immunotherapeutic approaches and pathogen-free herd selection.

Main Results:

• Successful long-term insulin independence achieved in diabetic models using pig islets.
• Insights gained into mechanisms of xenogeneic immune recognition and rejection.
• Demonstrated feasibility of obtaining adequate islet amounts through optimized sourcing and methods.

Conclusions:

• Pig islet xenotransplantation is a promising strategy for diabetes, with demonstrated preclinical success.
• Further research is required to enhance islet yield, quality, and overcome immune barriers.
• More safety and efficacy data are needed for successful clinical translation.